XTL BIOPHARMACEUTICALS LTD Annual Research And Development Expense in USD from 2015 to 2022

Taxonomy & unit
ifrs-full: USD
Summary
Xtl Biopharmaceuticals Ltd annual/quarterly Research And Development Expense history and growth rate from 2015 to 2022.
  • Xtl Biopharmaceuticals Ltd Research And Development Expense for the quarter ending June 30, 2022 was $15K, a 150% increase year-over-year.
  • Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2022 was $30K, unchanged from 2021.
  • Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2021 was $30K, a 21.1% decline from 2020.
  • Xtl Biopharmaceuticals Ltd annual Research And Development Expense for 2020 was $38K, a 8.57% increase from 2019.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $30K $0 0% Jan 1, 2022 Dec 31, 2022 20-F 2023-03-22
2021 $30K -$8K -21.1% Jan 1, 2021 Dec 31, 2021 20-F 2023-03-22
2020 $38K +$3K +8.57% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-22
2019 $35K -$3K -7.9% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-30
2018 $38K -$5K -11.6% Jan 1, 2018 Dec 31, 2018 20-F/A 2021-05-19
2017 $43K -$400K -90.3% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-12
2016 $443K -$135K -23.4% Jan 1, 2016 Dec 31, 2016 20-F 2019-03-11
2015 $578K Jan 1, 2015 Dec 31, 2015 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.